- Home
- SQNS vs IKNA Comparison
SQNS vs IKNA Comparison
Compare SQNS & IKNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQNS
- IKNA
- Stock Information
- Founded
- SQNS 2003
- IKNA 2016
- Country
- SQNS France
- IKNA United States
- Employees
- SQNS N/A
- IKNA N/A
- Industry
- SQNS Semiconductors
- IKNA Biotechnology: Pharmaceutical Preparations
- Sector
- SQNS Technology
- IKNA Health Care
- Exchange
- SQNS Nasdaq
- IKNA Nasdaq
- Market Cap
- SQNS 46.5M
- IKNA 63.7M
- IPO Year
- SQNS 2011
- IKNA 2021
- Fundamental
- Price
- SQNS $4.52
- IKNA $1.36
- Analyst Decision
- SQNS Strong Buy
- IKNA Strong Buy
- Analyst Count
- SQNS 1
- IKNA 1
- Target Price
- SQNS $7.50
- IKNA $4.00
- AVG Volume (30 Days)
- SQNS 9.6M
- IKNA 59.4K
- Earning Date
- SQNS 08-22-2025
- IKNA 08-07-2025
- Dividend Yield
- SQNS N/A
- IKNA N/A
- EPS Growth
- SQNS N/A
- IKNA N/A
- EPS
- SQNS 2.16
- IKNA N/A
- Revenue
- SQNS $38,858,000.00
- IKNA N/A
- Revenue This Year
- SQNS N/A
- IKNA N/A
- Revenue Next Year
- SQNS $93.87
- IKNA N/A
- P/E Ratio
- SQNS $2.08
- IKNA N/A
- Revenue Growth
- SQNS 40.06
- IKNA N/A
- 52 Week Low
- SQNS $0.95
- IKNA $0.97
- 52 Week High
- SQNS $5.50
- IKNA $1.94
- Technical
- Relative Strength Index (RSI)
- SQNS 87.95
- IKNA 53.81
- Support Level
- SQNS $1.34
- IKNA $1.31
- Resistance Level
- SQNS $2.68
- IKNA $1.42
- Average True Range (ATR)
- SQNS 0.52
- IKNA 0.05
- MACD
- SQNS 0.29
- IKNA -0.00
- Stochastic Oscillator
- SQNS 76.77
- IKNA 45.45
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its offer 5G/4G chips and modules fully optimized for non-smartphone devices. The company covers applications such as smart mobility and logistics, smart utility meters, smart cities, smart industries, e-health and wellness, and smart homes to name few. The Company has one operating segment, which is the design and marketing of semiconductor components for cellular wireless systems. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About IKNA Ikena Oncology Inc.
Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.